Back
BridgeBio Pharma Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
BBIO
BridgeBio Pharma
Last Price:
$37.52
Seasonality Move:
24.04%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.03 | Buy |
20-day SMA: | 34.22 | Buy |
50-day SMA: | 34.63 | Buy |
200-day SMA: | 30.1 | Buy |
8-day EMA: | 34.72 | Buy |
20-day EMA: | 34.45 | Buy |
50-day EMA: | 34.32 | Buy |
200-day EMA: | 31.5 | Buy |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 64.22 | Buy |
Chaikin Money Flow: | 2288700 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.01 - 36.95) | Buy |
Bollinger Bands (100): | (32.02 - 36.28) | Buy |
BridgeBio Pharma Technical Analysis
May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 37.52 while BBIO 8-day simple moving average is 34.03, which is a Buy signal.
-
The stock price of BBIO is 37.52 while BridgeBio Pharma 20-day SMA is 34.22, which makes it a Buy.
-
BridgeBio Pharma 50-day simple moving average is 34.63 while BBIO share price is 37.52, making it a Buy technically.
-
BBIO stock price is 37.52 and BridgeBio Pharma 200-day simple moving average is 30.10, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
48
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a SellThe current BridgeBio Pharma [BBIO] share price is $37.52. The Score for BBIO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
7.1B
Price in USD:
37.52
Share Volume:
3.1M
BridgeBio Pharma 52-Week Range
52-Week High:
39.54
52-Week Low:
21.62
Sell
48
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 37.52 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 37.52 while BBIO 8-day exponential moving average is 34.72, which is a Buy signal.
-
The stock price of BBIO is 37.52 while BridgeBio Pharma 20-day EMA is 34.45, which makes it a Buy.
-
BridgeBio Pharma 50-day exponential moving average is 34.32 while BBIO share price is 37.52, making it a Buy technically.
-
BBIO stock price is 37.52 and BridgeBio Pharma 200-day simple moving average is 31.50, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.22 per share, and an increase next year of $0.22 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting BridgeBio Pharma is a Buy
-
BridgeBio Pharma Relative Strength Index (RSI) is 64.22, which suggest BridgeBio Pharma is overbought
-
The Bollinger Bands (25) for BridgeBio Pharma is (33.01 - 36.95), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (32.02 - 36.28), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.